nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—Irbesartan—type 2 diabetes mellitus	0.175	0.389	CrCtD
Forasartan—Valsartan—type 2 diabetes mellitus	0.149	0.33	CrCtD
Forasartan—Losartan—type 2 diabetes mellitus	0.127	0.281	CrCtD
Forasartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0957	0.406	CbGbCtD
Forasartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.0853	0.361	CbGbCtD
Forasartan—AGTR1—Losartan—type 2 diabetes mellitus	0.055	0.233	CbGbCtD
Forasartan—Valsartan—Irbesartan—type 2 diabetes mellitus	0.0272	0.0938	CrCrCtD
Forasartan—Tasosartan—Irbesartan—type 2 diabetes mellitus	0.024	0.0829	CrCrCtD
Forasartan—Irbesartan—Valsartan—type 2 diabetes mellitus	0.0231	0.0797	CrCrCtD
Forasartan—Olmesartan—Irbesartan—type 2 diabetes mellitus	0.0216	0.0745	CrCrCtD
Forasartan—Tasosartan—Valsartan—type 2 diabetes mellitus	0.0204	0.0705	CrCrCtD
Forasartan—Irbesartan—Losartan—type 2 diabetes mellitus	0.0197	0.0678	CrCrCtD
Forasartan—Valsartan—Losartan—type 2 diabetes mellitus	0.0197	0.0678	CrCrCtD
Forasartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0197	0.0678	CrCrCtD
Forasartan—Olmesartan—Valsartan—type 2 diabetes mellitus	0.0184	0.0633	CrCrCtD
Forasartan—Candesartan—Irbesartan—type 2 diabetes mellitus	0.0181	0.0623	CrCrCtD
Forasartan—Tasosartan—Losartan—type 2 diabetes mellitus	0.0174	0.0599	CrCrCtD
Forasartan—Losartan—Valsartan—type 2 diabetes mellitus	0.0167	0.0576	CrCrCtD
Forasartan—Olmesartan—Losartan—type 2 diabetes mellitus	0.0156	0.0539	CrCrCtD
Forasartan—Candesartan—Valsartan—type 2 diabetes mellitus	0.0154	0.053	CrCrCtD
Forasartan—Candesartan—Losartan—type 2 diabetes mellitus	0.0131	0.0451	CrCrCtD
Forasartan—AGTR1—artery—type 2 diabetes mellitus	0.00144	0.265	CbGeAlD
Forasartan—AGTR1—endothelium—type 2 diabetes mellitus	0.00122	0.224	CbGeAlD
Forasartan—Tasosartan—AGTR2—type 2 diabetes mellitus	0.000847	0.485	CrCbGaD
Forasartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000559	0.103	CbGeAlD
Forasartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000502	0.0921	CbGeAlD
Forasartan—AGTR1—kidney—type 2 diabetes mellitus	0.000491	0.0902	CbGeAlD
Forasartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000478	0.0878	CbGeAlD
Forasartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000443	0.0813	CbGeAlD
Forasartan—AGTR1—liver—type 2 diabetes mellitus	0.00031	0.057	CbGeAlD
Forasartan—Irbesartan—EDNRA—type 2 diabetes mellitus	0.000289	0.166	CrCbGaD
Forasartan—Olmesartan—ABCC2—type 2 diabetes mellitus	0.000152	0.0872	CrCbGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCKAR—type 2 diabetes mellitus	0.000115	0.00707	CbGpPWpGaD
Forasartan—AGTR1—Arf6 signaling events—SRC—type 2 diabetes mellitus	0.000115	0.00702	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.000111	0.00684	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—type 2 diabetes mellitus	0.00011	0.00672	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.000106	0.00653	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.000104	0.0064	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.000103	0.00629	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.000101	0.00619	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AGTR2—type 2 diabetes mellitus	0.000101	0.00618	CbGpPWpGaD
Forasartan—AGTR1—Arf6 signaling events—EGFR—type 2 diabetes mellitus	0.0001	0.00616	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	9.77e-05	0.00599	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—EDNRB—type 2 diabetes mellitus	9.64e-05	0.00592	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	9.48e-05	0.00582	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	9.41e-05	0.00577	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GIPR—type 2 diabetes mellitus	9.28e-05	0.00569	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—type 2 diabetes mellitus	9.24e-05	0.00567	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	9.22e-05	0.00566	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	9.17e-05	0.00563	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	9.12e-05	0.0056	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—EDNRA—type 2 diabetes mellitus	9.11e-05	0.00559	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—CASP8—type 2 diabetes mellitus	9.05e-05	0.00556	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	9.02e-05	0.00553	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	8.99e-05	0.00551	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—GHRL—type 2 diabetes mellitus	8.87e-05	0.00544	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	8.73e-05	0.00536	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	8.49e-05	0.00521	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	8.48e-05	0.0052	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	8.25e-05	0.00506	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	8.22e-05	0.00504	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GIP—type 2 diabetes mellitus	8.17e-05	0.00501	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	8.09e-05	0.00496	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	8.06e-05	0.00494	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	8.04e-05	0.00493	CbGpPWpGaD
Forasartan—Tasosartan—CYP3A4—type 2 diabetes mellitus	7.96e-05	0.0456	CrCbGaD
Forasartan—Irbesartan—CYP1A2—type 2 diabetes mellitus	7.9e-05	0.0453	CrCbGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	7.88e-05	0.00484	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	7.73e-05	0.00474	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	7.55e-05	0.00463	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	7.35e-05	0.00451	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	7.33e-05	0.0045	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	7.23e-05	0.00444	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—type 2 diabetes mellitus	7.19e-05	0.00441	CbGpPWpGaD
Forasartan—Losartan—ACE—type 2 diabetes mellitus	7.18e-05	0.0411	CrCbGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	7.13e-05	0.00437	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	7.09e-05	0.00435	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	6.99e-05	0.00429	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	6.98e-05	0.00428	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	6.95e-05	0.00426	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AVP—type 2 diabetes mellitus	6.9e-05	0.00423	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—CASP3—type 2 diabetes mellitus	6.85e-05	0.0042	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	6.75e-05	0.00414	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	6.71e-05	0.00412	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	6.65e-05	0.00408	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	6.6e-05	0.00405	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—EDN1—type 2 diabetes mellitus	6.56e-05	0.00403	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	6.47e-05	0.00397	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	6.34e-05	0.00389	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	6.28e-05	0.00385	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	6.25e-05	0.00384	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	6.25e-05	0.00384	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	6.14e-05	0.00377	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	6.11e-05	0.00375	CbGpPWpGaD
Forasartan—Valsartan—ALB—type 2 diabetes mellitus	6.02e-05	0.0345	CrCbGaD
Forasartan—AGTR1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	6e-05	0.00368	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	5.98e-05	0.00367	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	5.98e-05	0.00367	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	5.95e-05	0.00365	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	5.95e-05	0.00365	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	5.88e-05	0.00361	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCR5—type 2 diabetes mellitus	5.87e-05	0.0036	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	5.81e-05	0.00357	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—C3—type 2 diabetes mellitus	5.73e-05	0.00352	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	5.7e-05	0.0035	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	5.52e-05	0.00339	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AGT—type 2 diabetes mellitus	5.45e-05	0.00334	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—type 2 diabetes mellitus	5.35e-05	0.00328	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	5.34e-05	0.00327	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	5.3e-05	0.00325	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	5.25e-05	0.00322	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	5.25e-05	0.00322	CbGpPWpGaD
Forasartan—Irbesartan—CYP3A4—type 2 diabetes mellitus	5.23e-05	0.03	CrCbGaD
Forasartan—AGTR1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	5.18e-05	0.00318	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	5.14e-05	0.00316	CbGpPWpGaD
Forasartan—Losartan—CYP1A2—type 2 diabetes mellitus	5.09e-05	0.0292	CrCbGaD
Forasartan—AGTR1—Allograft Rejection—TNF—type 2 diabetes mellitus	4.98e-05	0.00306	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	4.94e-05	0.00303	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	4.93e-05	0.00302	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	4.9e-05	0.00301	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	4.8e-05	0.00294	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	4.78e-05	0.00293	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	4.76e-05	0.00292	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	4.76e-05	0.00292	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	4.65e-05	0.00285	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	4.63e-05	0.00284	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	4.62e-05	0.00283	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	4.59e-05	0.00282	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	4.55e-05	0.00279	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	4.53e-05	0.00278	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCL2—type 2 diabetes mellitus	4.49e-05	0.00275	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	4.48e-05	0.00275	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	4.48e-05	0.00275	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	4.4e-05	0.0027	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	4.36e-05	0.00267	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GIP—type 2 diabetes mellitus	4.19e-05	0.00257	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GCG—type 2 diabetes mellitus	4.15e-05	0.00254	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	4.05e-05	0.00249	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	3.94e-05	0.00241	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	3.93e-05	0.00241	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	3.85e-05	0.00236	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	3.79e-05	0.00233	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	3.65e-05	0.00224	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	3.62e-05	0.00222	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	3.57e-05	0.00219	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	3.57e-05	0.00219	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	3.54e-05	0.00217	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AVP—type 2 diabetes mellitus	3.53e-05	0.00216	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	3.47e-05	0.00213	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	3.44e-05	0.00211	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	3.38e-05	0.00207	CbGpPWpGaD
Forasartan—Losartan—CYP3A4—type 2 diabetes mellitus	3.37e-05	0.0193	CrCbGaD
Forasartan—AGTR1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	3.35e-05	0.00206	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	3.33e-05	0.00204	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	3.15e-05	0.00193	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	3.07e-05	0.00188	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	3.06e-05	0.00188	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	3.02e-05	0.00185	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	3.01e-05	0.00185	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	3e-05	0.00184	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	2.99e-05	0.00184	CbGpPWpGaD
Forasartan—Losartan—ALB—type 2 diabetes mellitus	2.94e-05	0.0169	CrCbGaD
Forasartan—AGTR1—GPCR ligand binding—C3—type 2 diabetes mellitus	2.93e-05	0.0018	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	2.92e-05	0.00179	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	2.91e-05	0.00178	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.81e-05	0.00173	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.81e-05	0.00173	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	2.78e-05	0.00171	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	2.78e-05	0.00171	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	2.72e-05	0.00167	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	2.7e-05	0.00166	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.65e-05	0.00163	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.64e-05	0.00162	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.63e-05	0.00161	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.57e-05	0.00158	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.57e-05	0.00158	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.56e-05	0.00157	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.53e-05	0.00155	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.53e-05	0.00155	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.48e-05	0.00152	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.45e-05	0.00151	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.39e-05	0.00146	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.35e-05	0.00144	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.35e-05	0.00144	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.34e-05	0.00144	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.34e-05	0.00143	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.33e-05	0.00143	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.3e-05	0.00141	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.3e-05	0.00141	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.29e-05	0.00141	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.25e-05	0.00138	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.19e-05	0.00134	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.13e-05	0.00131	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.11e-05	0.00129	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.09e-05	0.00128	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.03e-05	0.00125	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.02e-05	0.00124	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.99e-05	0.00122	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.89e-05	0.00116	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.88e-05	0.00115	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.86e-05	0.00114	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.86e-05	0.00114	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.83e-05	0.00113	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.81e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.81e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.81e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.81e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.81e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.8e-05	0.0011	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.78e-05	0.00109	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.72e-05	0.00106	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.69e-05	0.00104	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.66e-05	0.00102	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.63e-05	0.001	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.62e-05	0.000992	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.61e-05	0.000985	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.6e-05	0.000979	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.57e-05	0.000965	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.57e-05	0.000962	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.57e-05	0.000961	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.56e-05	0.000957	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.54e-05	0.000944	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.5e-05	0.000922	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.49e-05	0.000916	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.45e-05	0.000892	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.45e-05	0.000889	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.45e-05	0.000889	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.43e-05	0.000876	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.41e-05	0.000865	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.4e-05	0.000862	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.4e-05	0.000861	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.38e-05	0.000847	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.37e-05	0.000843	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.37e-05	0.000843	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.36e-05	0.000833	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.32e-05	0.00081	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.28e-05	0.000784	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.27e-05	0.000781	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.26e-05	0.000771	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.26e-05	0.000771	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.24e-05	0.000759	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.23e-05	0.000756	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.18e-05	0.000722	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.16e-05	0.000709	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000708	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.09e-05	0.000671	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.08e-05	0.000665	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.07e-05	0.000656	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.07e-05	0.000656	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.06e-05	0.000653	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.06e-05	0.00065	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.05e-05	0.000643	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.03e-05	0.000634	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.03e-05	0.000631	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.02e-05	0.000624	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.86e-06	0.000605	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.65e-06	0.000592	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.25e-06	0.000568	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.09e-06	0.000557	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	8.88e-06	0.000545	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.47e-06	0.00052	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.45e-06	0.000518	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.44e-06	0.000518	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.3e-06	0.000509	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.27e-06	0.000507	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.27e-06	0.000507	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.17e-06	0.000501	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.8e-06	0.000478	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.37e-06	0.000452	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	7.06e-06	0.000433	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.95e-06	0.000426	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.83e-06	0.000419	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.83e-06	0.000419	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.8e-06	0.000417	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.49e-06	0.000398	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.19e-06	0.00038	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.19e-06	0.00038	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.83e-06	0.000358	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.31e-06	0.000326	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.26e-06	0.000323	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.22e-06	0.00032	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.97e-06	0.000305	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.92e-06	0.000302	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.82e-06	0.000296	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.58e-06	0.000281	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.46e-06	0.000274	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.1e-06	0.000251	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.02e-06	0.000246	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.09e-06	0.000189	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.85e-06	0.000175	CbGpPWpGaD
